Tregalizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tregalizumab
Monoclonal antibody
Type Whole antibody
Source Humanized
Target CD4
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 NYesY (what is this?)  (verify)

Tregalizumab is an immunomodulator. It binds to CD4.[1]

References[edit]

  1. ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information. 24 (4).